Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,851
Total Claims
$1.0M
Drug Cost
836
Beneficiaries
$1,216
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-90%
Opioid rate vs peers
0.2% vs 2.5% avg
+8%
Cost per patient vs peers
$1,216 vs $1,128 avg
+9%
Brand preference vs peers
9.1% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.2%
Opioid Rate
44
Opioid Claims
$494
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,614 claims · $765K
Generic: 16,080 claims · $248K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phos/Metformin Hcl | 63 | $81K |
| Insulin Glargine,hum.Rec.Anlog | 93 | $73K |
| Levothyroxine Sodium | 502 | $52K |
| Sitagliptin Phosphate | 33 | $51K |
| Apixaban | 40 | $39K |
| Dapagliflozin Propanediol | 24 | $37K |
| Rivaroxaban | 32 | $34K |
| Sitagliptin Phos/Metformin Hcl | 24 | $32K |
| Insulin Nph Hum/Reg Insulin Hm | 77 | $30K |
| Dapaglifloz Propaned/Metformin | 16 | $25K |
| Dulaglutide | 20 | $21K |
| Budesonide/Formoterol Fumarate | 35 | $14K |
| Ticagrelor | 14 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 27 | $14K |
| Insulin Lispro | 18 | $13K |
Prescribing Profile
Patient Profile
71
Avg Age
61%
Female
1.60
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data